SE0301654D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- SE0301654D0 SE0301654D0 SE0301654A SE0301654A SE0301654D0 SE 0301654 D0 SE0301654 D0 SE 0301654D0 SE 0301654 A SE0301654 A SE 0301654A SE 0301654 A SE0301654 A SE 0301654A SE 0301654 D0 SE0301654 D0 SE 0301654D0
- Authority
- SE
- Sweden
- Prior art keywords
- novel compounds
- pyridazine
- therapy
- triazine compounds
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/22—Nitrogen and oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0301654A SE0301654D0 (sv) | 2003-06-05 | 2003-06-05 | Novel compounds |
| TW093114511A TW200509935A (en) | 2003-06-05 | 2004-05-21 | Novel compounds |
| PCT/SE2004/000851 WO2004108690A1 (en) | 2003-06-05 | 2004-06-02 | Sulphonamide compounds that modulate chemokine receptor activity (ccr4) |
| US10/559,202 US20060189613A1 (en) | 2003-06-05 | 2004-06-02 | Sulphonamide Compounds that Modulate Chemokine Receptor Activity (CCR4) |
| EP04735834A EP1633723A1 (en) | 2003-06-05 | 2004-06-02 | Sulphonamide compounds that modulate chemokine receptor activity (ccr4) |
| JP2006508571A JP2006526619A (ja) | 2003-06-05 | 2004-06-02 | ケモカイン受容体活性（ｃｃｒ４）を調節するスルホンアミド化合物 |
| UY28345A UY28345A1 (es) | 2003-06-05 | 2004-06-03 | Compuestos novedosos |
| ARP040101942A AR044613A1 (es) | 2003-06-05 | 2004-06-04 | Heteroaril derivados de sulfonamidas como moduladores del receptor de quimioquina (ccr4) |
| SA04250149A SA04250149A (ar) | 2003-06-05 | 2004-06-05 | مركبات جديدة |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0301654A SE0301654D0 (sv) | 2003-06-05 | 2003-06-05 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE0301654D0 true SE0301654D0 (sv) | 2003-06-05 |
Family
ID=29212393
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE0301654A SE0301654D0 (sv) | 2003-06-05 | 2003-06-05 | Novel compounds |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20060189613A1 (ar) |
| EP (1) | EP1633723A1 (ar) |
| JP (1) | JP2006526619A (ar) |
| AR (1) | AR044613A1 (ar) |
| SA (1) | SA04250149A (ar) |
| SE (1) | SE0301654D0 (ar) |
| TW (1) | TW200509935A (ar) |
| UY (1) | UY28345A1 (ar) |
| WO (1) | WO2004108690A1 (ar) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI328007B (en) * | 2002-01-16 | 2010-08-01 | Astrazeneca Ab | Novel compounds |
| SE0301650D0 (sv) * | 2003-06-04 | 2003-06-04 | Astrazeneca Ab | Novel compounds |
| SE0301653D0 (sv) * | 2003-06-05 | 2003-06-05 | Astrazeneca Ab | Novel compounds |
| US20090182140A1 (en) * | 2005-12-02 | 2009-07-16 | Mitsubishi Tanabe Pharma Corporation | Alicyclic Heterocyclic Compound |
| EP1956009A1 (en) * | 2005-12-02 | 2008-08-13 | Mitsubishi Tanabe Pharma Corporation | Aromatic compound |
| TW200730512A (en) * | 2005-12-12 | 2007-08-16 | Astrazeneca Ab | Novel compounds |
| WO2009151910A2 (en) * | 2008-05-25 | 2009-12-17 | Wyeth | Combination product of receptor tyrosine kinase inhibitor and fatty acid synthase inhibitor for treating cancer |
| AU2014267360B2 (en) | 2013-05-14 | 2018-07-05 | Active Biotech Ab | N-(heteroaryl)-sulfonamide derivatives useful as S100-inhibitors |
| TW201811766A (zh) | 2016-08-29 | 2018-04-01 | 瑞士商諾華公司 | N-(吡啶-2-基)吡啶-磺醯胺衍生物及其用於疾病治療之用途 |
| BR112020009055A2 (pt) * | 2017-11-06 | 2020-11-03 | Rapt Therapeutics, Inc. | moduladores de receptor de quimiocina para tratamento de câncer positivo para vírus epstein barr |
| US20230030720A1 (en) | 2018-12-06 | 2023-02-02 | Daiichi Sankyo Company, Limited | Cycloalkane-1,3-diamine derivative |
| WO2020161623A1 (en) * | 2019-02-06 | 2020-08-13 | Novartis Ag | N-(pyridin-2-yl)pyridine-sulfonamide derivatives and their use in the treatment of disease |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5962490A (en) * | 1987-09-25 | 1999-10-05 | Texas Biotechnology Corporation | Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| KR100835770B1 (ko) * | 2000-09-25 | 2008-06-09 | 액테리온 파마슈티칼 리미티드 | 엔도텔린 길항 활성을 갖는 아릴알칸-설폰아마이드 |
| WO2002030357A2 (en) * | 2000-10-11 | 2002-04-18 | Chemocentryx, Inc. | Compounds and methods for modulating ccr4 function |
| US20060004010A1 (en) * | 2002-07-10 | 2006-01-05 | Hiromu Habashita | Ccr4 antagonist and medical use thereof |
| SE0301650D0 (sv) * | 2003-06-04 | 2003-06-04 | Astrazeneca Ab | Novel compounds |
| SE0301653D0 (sv) * | 2003-06-05 | 2003-06-05 | Astrazeneca Ab | Novel compounds |
-
2003
- 2003-06-05 SE SE0301654A patent/SE0301654D0/xx unknown
-
2004
- 2004-05-21 TW TW093114511A patent/TW200509935A/zh unknown
- 2004-06-02 EP EP04735834A patent/EP1633723A1/en not_active Withdrawn
- 2004-06-02 US US10/559,202 patent/US20060189613A1/en not_active Abandoned
- 2004-06-02 WO PCT/SE2004/000851 patent/WO2004108690A1/en active Application Filing
- 2004-06-02 JP JP2006508571A patent/JP2006526619A/ja active Pending
- 2004-06-03 UY UY28345A patent/UY28345A1/es not_active Application Discontinuation
- 2004-06-04 AR ARP040101942A patent/AR044613A1/es unknown
- 2004-06-05 SA SA04250149A patent/SA04250149A/ar unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR044613A1 (es) | 2005-09-21 |
| WO2004108690A1 (en) | 2004-12-16 |
| JP2006526619A (ja) | 2006-11-24 |
| UY28345A1 (es) | 2005-01-31 |
| EP1633723A1 (en) | 2006-03-15 |
| US20060189613A1 (en) | 2006-08-24 |
| TW200509935A (en) | 2005-03-16 |
| SA04250149A (ar) | 2005-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200202194T2 (tr) | Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri | |
| ATE461217T1 (de) | Glp-1-verbindungen | |
| AU302959S (en) | Toothbrush | |
| DE60310576D1 (en) | 2-hydroxy-6-phenylphenanthridine als pde-4-hemmer | |
| IS7520A (is) | Pyrimidínonefnasambönd, samsetningar og aðferðir | |
| MXPA05011643A (es) | 5,7-diaminopirazolo[4,3-d]pirimidinas en el tratamiento de hipertension. | |
| NL1025068A1 (nl) | Pyrrolopyrimidinederivaten. | |
| MX267068B (es) | Derivados simetricos de triazina. | |
| RS50660B (sr) | Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže | |
| MXPA03007140A (es) | Derivados de carbolina. | |
| DK1585737T3 (da) | Uraciler med herbicid virkning | |
| HK1083503A1 (en) | Novel pyrimidine-4, 6-dicarboxamides for the selective inhibition of collagenases | |
| SE0301654D0 (sv) | Novel compounds | |
| EA200800223A1 (ru) | ПРОИЗВОДНЫЕ ПИРИДО[2,3-d]ПИРИМИДИНА, ИХ ПОЛУЧЕНИЕ, ИХ ПРИМЕНЕНИЕ В ТЕРАПИИ | |
| TW200510398A (en) | Novel compounds | |
| NO20081292L (no) | Pentasykliske kinaseinhibitorer | |
| NO20054053D0 (no) | Triazolforbindelser anvendbare i terapi. | |
| IS7507A (is) | Ný efnasambönd | |
| DK1496918T3 (da) | Anvendelse af natriummetaarsenit til behandling af tumorer | |
| ATE391489T1 (de) | Haarbehandlungszusammensetzungen | |
| NO20053189D0 (no) | HVC-kombinasjonsterapi. | |
| DE602004030231D1 (de) | Pyrimidinonverbindungen als calcilytica | |
| ITMI20022028A1 (it) | Fenton i.s. | |
| ITMO20020368A1 (it) | Mezzi di finitura perfezionati. | |
| AU301500S (en) | Laser leveling device |